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Introduction
Cancers from lung and esophagus are the most common cancers and remain the leading causes of cancer-related deaths in China. For both cancers, squamous cell carcinoma is the predominant histopathological type and cigarette smoking and alcohol consumption are the main risk factors [1] [2] [3] [4] [5] . The concurrent occurrence of malignant lesions from lung and esophagus is not uncommon. Lung is the most common site for secondary primary malignancies in patients with esophageal cancer [4] . Accumulating evidence indicates that lung and esophageal cancers share many common genetic variants, such as deletion of CASP and CYP2A6 gene [3, 6] , SOX2 expression [2] , IFGR-IGFBP axis [7] and WDHD1 [8] , especially in an Asian population.
Recently, a couple of genome-wide association studies (GWAS) demonstrated that a group of common genetic variants increase the risk to tumors from esophagus, lung and stomach [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Notably, the SNPs among these genetic variants have not been well characterized in lung cancer from Chinese Han population. Based on the published GWAS data from lung cancer, esophageal squamous cell carcinoma (ESCC) and gastric adenocarcinoma (GA), a group of 20 SNPs of interest were selected to determine their relevance on the susceptibility and prognosis in 1170 patients with lung cancer and 1530 healthy control subjects from northern China.
Methods

Ethics statement
The study was approved by the Ethics Committee of The First Affiliated Hospital of Zhengzhou University, China and conducted according to Declaration of Helsinki principles. Written informed consent was obtained from all participants.
Patients and follow-up
For genotyping, 1170 lung cancer patients were enrolled in this study from January 1, 2011 to December 31, 2012 , including 811 males with a mean age of 60±12 years (mean±SD) and 359 females with a mean age of 58±13 years. All patients were Chinese Han descent and were from multiple hospitals across Henan province, northern China, one of the high-incidence areas for both ESCC and GA. Detailed clinical information including histological type, lymph node metastasis, pathological stage, family history, cigarette smoking and treatment methods were retrieved from medical records. All patients were followed up until the end of 2014 with a median of 3.5 years. Survival status was available for all the patients genotyped in this study. In addition, 1530 healthy control subjects of Chinese Han descent were from the same regions of above lung cancer patients. 5ml peripheral venous blood was extracted from all the subjects enrolled in this study, blood DNA from all the subjects were retrospectively genotyped.
Family history was self-reported and defined as any first-degree relatives (parents or siblings) who had been diagnosed with lung cancer reported by the subjects. Positive smoking history was defined as more than 15 pack-years. Never smokers were individuals who reported smoking less than 100 cigarettes in their lifetime [22] . TNM stages were defined according to the seventh edition of the American Joint Committee on Cancer staging system, published in 2009 [23] .
DNA extraction and SNP genotyping DNA was extracted from buffy coat of 1170 patients diagnosed with lung cancer and 1530 healthy controls using Puregene Kit (Qiagen, Valencia, CA, USA). All DNA samples were genotyped for the 20 susceptibility SNPs at 17 risk loci derived from lung cancer, ESCC or GA using TaqMan allelic discrimination assays (Applied Biosystems, Foster City, CA, USA). The reaction consisted of 2μl of 10 ng/μl DNA, 0.5μl of 2ⅹTaqman Universal PCR Master Mix, No AmpErase UNG (Bio-Rad, Hercules, CA, USA). The fluorescent intensities of each sample were measured before and after PCR using an Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems). Data obtained was analyzed and genotypes assigned using 7300 System SDS Software, version 1.4 (Applied Biosystems). Because of less quantity and poor quality of DNA, 1005 effective genotypes with lung cancer and 1473 effective genotypes with healthy control were obtained in our study finally. 
Statistical analyses
Results
People characteristics
The information, including age and gender of the subjects involved in the present study, were summarized in Table 1 . The mean ages for male and female lung cancer patients and healthy 
Lung cancer susceptibility genotypes
The distribution of genotypes in this patient cohort was shown in Table 2 . Twenty SNPs in 17 genes (Tables 2 and 3) were analyzed for association with the risk of lung cancer. Finally, five SNPs (rs3769823, rs10931936, rs2244438, rs13016963, rs7578456) were significant association with the increased risk of lung cancer in the high-incidence area of ESCC in northern China with p value of 0.001, 0.002, 0.002, 0.002 and 0.007. However, after Bonferroni correction multiple comparisons, of the original five significant SNPs, one SNP (rs7578456) was identified without significant p value (0.14). The other four SNPs (rs3769823, rs2244438, rs10931936, and rs13016963) showed significant associations with the increased risk of lung cancer with p value of 0.02, 0.04, 0.04 and 0.04, respectively. The 95% CIs were shown in Table 2 . High linkage disequilibrium SNPs, which map to a region including CASP8, ALS2CR12 and TRAK2, identified as high-risk SNPs in Chinese esophageal cancer, showed significant associations with the increased risk of lung cancer.
Relationships between lung cancer susceptibility SNPs and overall survival
To test whether these ESCC and lung cancer susceptibility SNPs variants correlate with the overall survival of lung cancer patients, we performed Kaplan-Meier survival analyses. Our Single nucleotide polymorphism in high risk susceptibility to lung cancer results showed that no significant differences between overall survival (OS) and these SNPs were observed in patients (P>0.05; Table 4 ). 599 patients were genotyped for rs3769823, 579 for rs10931936, 600 for rs2244438, 596 for 13016963, respectively. Kaplan-Meier curve of OS for rs3769823 genotype was shown in Fig 1. Log-rank tests showed no significant difference between OS and rs10931936 genotype (log-rank P = 0.488). Fig 2 showed Kaplan-Meier curve of OS for rs10931936 genotype. OS of the TT genotype group increased in comparison with CT and AG genotype groups but without statistical significance. Kaplan-Meier curves of OS for rs2244438, rs13016963 genotypes were shown in Figs 3 and 4 , respectively, and Log-rank analysis showed no significant differences between OS and these genotypes (log-rank P = 0.101, P = 0.938, P = 0.711, respectively). Table 5 summarizes the baseline characteristics of patients in this study. Among 1170 lung cancer patients, the main histopathological types were adenocarcinoma and squamous cell carcinoma. The majority of male patients of lung cancer were smokers. We found that rs10931936 CT genotype was borderline significantly associated with an increase risk in male subgroup (P = 0.086; Table 5 ). No statistically significant differences were found between four genotypes and gender, tumor types, grades, smoking and family history (P> 0.05, Table 5 ) when genotype and the allele distribution of polymorphisms were compared. The uninformative cases were due to lost of connection or low genome QC level. Single nucleotide polymorphism in high risk susceptibility to lung cancer
Associations between the four risk genotypes of lung cancer and clinical characteristics
Discussion
In this study, we investigated the association between lung cancer and these functional polymorphisms at 2q33 predisposing to the risk of ESCC. The patients with lung cancer we studied came from high-incidence regions of ESCC, where exhibits a considerable high-incidence of lung cancer as well. Of all 20 SNPs, 6 SNPs were risk loci of ESCC, 12 SNPs were susceptibility loci of LC and only 2 SNPs were associated with GC. Interestingly, 4 of the 6 ESCC susceptibility SNPs showed significant association with LC in high-incidence areas of ESCC in northern China. All the ESCC patients associated with the six SNPs were Chinese people, and majority of them were from high-incidence area of ESCC in China. The fact may reveal lung cancer and ESCC may share many similar genetic variants. However, none of the 12 LC susceptibility SNPs showed significant association with LC in this study. Only 3 LC SNPs were from Chinese, other 9 of them were from foreigners. The result may indicate that there are significant regional and ethnic differences in susceptibility to lung cancer. Our data revealed that four functional polymorphisms at 2q33 (rs13016963, rs3769823, rs10931936, rs2244438) out of 20 SNPs were associated with the risk of lung cancer (P< 0.01) and ESCC of Chinese Han as well. However, we did not find evidence of significant associations between overall survival of lung cancer and any of the four SNPs at 2q33.
Unlike highly penetrant germline mutations causing 'hereditary' cancers, such as CDKN2A mutations in melanoma and BRCA1 mutations in breast cancer, lung cancer and ESCC belong to 'sporadic' ('non-hereditary') malignant phenotype but a number of recent studies of heritability assessment suggests that these phenotypes (include twelve cancer types) of sporadic tumors share common genetic variants [24] . In other words, the genetic variants in cancer Single nucleotide polymorphism in high risk susceptibility to lung cancer susceptibility play important roles in several common cancers and more loci of remaining polygenic components should be discovered continuously. The effects of genes and common environmental factors on heritability should not simply be distinguished [24] . In fact, more novel cancer susceptibility loci identified by GWAS and contribution of all genetic variants to malignant disease should be simultaneously taken into consideration instead of just few known loci [9, 25, 26] . Numerous studies investigated whether variation in the CASP8 [27, 28] gene region alters cancer risk, including cancers of lung [29] , breast [30] , pancreas [31] , non-Hodgkin lymphoma [32] , head and neck [3] . We identified two new loci (rs3769823, rs10931936) mapping to a genomic region harboring CASP8 which associated with risk of both ESCC and lung cancer of Chinese Han. We are the first to report that SNPs mapping to ALS2CR12 and TRAK2 were significantly associated with ESCC and lung cancer of Chinese Han [33, 34] . Overall survival of allele rs10931936 TT genotype was increased compared with CT and CC genotype groups but without statistical significance (Fig 2, log-rank P = 0.101; Table 4 ). The cause may be due to the withdrawal of some cases from our follow-up and only informative 29 cases available for analysis. In addition, genotype CT in rs10931936 was borderline significantly associated with an increased risk in male subgroup (Table 5) . Therefore, rs10931936 genotype group that map to CASP8 need further investigation to elucidate [9] . Further research should focus on the association between functional polymorphisms at 2q33 (rs13016963, rs3769823, rs10931936, rs2244438) and risk of lung cancer from different ethnics, other tumor types and as well as the association with chemotherapy treatments in China.
So far, at least three studies on GWAS reported that rs8034191 was involved in the susceptibility to lung cancer [15] [16] [17] . However, our data from particular Chinese region found that rs8034191 was not associated with the risk of lung cancer. Furthermore, other investigations provided similar evidence that other SNPs may not modify the genetic risk of lung cancer, which include rs8034191, rs4975616, rs2352028, rs1926293 [35] [36] [37] [38] . The discrepancy could be due to differences of ethnic, region, genotyping platform or study sizes.
The limitations of the present study are threefold. First, our analysis was only limited to a couple of regions in Northern China. Second, the sample size in our validation phase was smaller than the original studies. Third, the follow-up time was short for overall survival investigation.
Conclusions
Our present results suggest that four genetic variants in 2q33 may contribute to the susceptibility to both lung and esophageal cancers in Han Chinese. However, we did not find an association between these four lung cancer risk variants with survival. In addition, our findings also showed that 16 common genetic variants that have been previously identified in lung cancer, ESCC or GA by GWAS were not associated with lung cancer susceptibility in the Han Chinese population.
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